| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/04/2011 | US8030451 Isolated bitter taste receptor polypeptides |
| 10/04/2011 | US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides |
| 10/04/2011 | US8030009 Human T2R67 taste receptor and related assays for identifying human bitter taste modulators |
| 10/04/2011 | US8029803 Chimeric antigens for eliciting an immune response |
| 10/04/2011 | US8029789 Method for the mass production of immunoglobulin constant region |
| 10/04/2011 | CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production |
| 10/04/2011 | CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 09/29/2011 | WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | WO2011119628A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 09/29/2011 | WO2011118599A1 Filler for affinity chromatography and method for isolating immunoglobulin |
| 09/29/2011 | WO2011117728A2 Novel cbh1-eg1 fusion proteins and use thereof |
| 09/29/2011 | WO2011070214A8 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 09/29/2011 | WO2011056899A3 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| 09/29/2011 | US20110237777 Fusion protein containing a single-stranded dna binding protein and methods for expression and purification of the same |
| 09/29/2011 | US20110237500 Cecropin-magainin hybrid peptides |
| 09/29/2011 | US20110237499 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237448 Carbohydrate binding module with affinity for insoluble xylan |
| 09/29/2011 | US20110236931 Chemical and biochemical adducts as biomarkers for organophosphate exposure |
| 09/29/2011 | US20110236913 Compostion and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy |
| 09/29/2011 | US20110236411 MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics |
| 09/29/2011 | US20110236408 Respiratory synctial virus (rsv) sequences for protein expression and vaccines |
| 09/29/2011 | US20110236406 Immunogenic compositions comprising hmgb1 polypeptides |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236385 Blocking mesothelin peptide fragments |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236375 Antibody variants with enhanced complement activity |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | CA2794483A1 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | CA2794167A1 Bmp-7 peptides & methods of use |
| 09/29/2011 | CA2794165A1 Bmp-4 peptides & methods of use |
| 09/28/2011 | EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 09/28/2011 | EP2367841A2 Peptide tag and uses thereof |
| 09/28/2011 | EP2367568A2 Meningococcal vaccines including hemoglobin receptor |
| 09/28/2011 | CN102203618A Membrane-integrated viral dna-packaging motor protein connector biosensor for DNA sequencing and other uses |
| 09/28/2011 | CN102199617A Dengue virus subunit vaccine and preparation method thereof |
| 09/28/2011 | CN102199218A Fusion protein of Her2 antibody and interleukin 2 and application thereof |
| 09/28/2011 | CN102199217A Hepatitis B virus multi-epitope fusion protein and preparation method and application thereof |
| 09/28/2011 | CN102199216A New dendritic cell co-stimulatory molecules |
| 09/28/2011 | CN102199215A MAPWA fusion antibacterial peptide, preparation method and application thereof |
| 09/28/2011 | CN102199214A Protein preparation method |
| 09/28/2011 | CN102199208A Universal medicine delivery system and preparation method thereof |
| 09/27/2011 | US8026351 Monocyte-derived nucleic acids and related compositions and methods |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | CA2408034C Recombinant sequence, its preparation and use |
| 09/22/2011 | WO2011115583A1 A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens |
| 09/22/2011 | WO2011115458A2 Dual antagonist for tnf-α and il-21 for preventing and treating autoimmune diseases |
| 09/22/2011 | WO2011115456A2 Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases |
| 09/22/2011 | WO2011115323A1 Composition for inhibiting cancer metastasis containing dlk1-fc fusion protein as an active ingredient |
| 09/22/2011 | WO2011094617A3 Peptide domains that bind small molecules of industrial significance |
| 09/22/2011 | US20110231960 Bacterial toxin vaccine |
| 09/22/2011 | US20110230649 Compositions and Methods for Redox Modulated Proteins |
| 09/22/2011 | US20110230637 Modified human thymic stromal lymphopoietin |
| 09/22/2011 | US20110230421 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminus of ec-sod |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | CA2793671A1 Bmp-2 peptides & methods of use |
| 09/22/2011 | CA2792413A1 Composition for the anti-cancer metastasis containing dlk1-fc fusion protein as an effective ingredient |
| 09/21/2011 | EP2366715A2 Rankl Antibody-PTH/PTHRP Chimeric Molecules |
| 09/21/2011 | EP1507003B1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 09/21/2011 | EP1492811B1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1135408B1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/21/2011 | CN1979165B Alpha-fodrin antigen epi-position polypeptide mixture and its use |
| 09/21/2011 | CN102190735A Fusion protein TAT (transactivator of transcription)-OCT4 (octamer-binding transcription factor 4), and coding gene and application thereof |
| 09/21/2011 | CN102190734A Tubercle bacillus fusion protein Mtb8.4-HspX, and preparation method and application thereof |
| 09/21/2011 | CN102190733A Tag-free tubercle bacillus fusion protein ESAT6-RpfE and preparation method and application thereof |
| 09/21/2011 | CN102190732A PGBD-2 fusion defensin, and preparation method and application thereof |
| 09/21/2011 | CN102190731A Artificial transcription factor induced pluripotent stem cells |
| 09/21/2011 | CN102190730A Biotin protein ligase fusion protein |
| 09/21/2011 | CN101092616B Expressing and purifying neutrophilic granule protein NGP |
| 09/20/2011 | US8022190 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 09/20/2011 | US8022182 Truncated BAFF receptors |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021856 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2400562C Hybrid expression of neisserial proteins |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2331258C Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011113027A2 Npp1 fusion proteins |
| 09/15/2011 | WO2011112935A2 Antibody fusion proteins with disrupted heparin-binding activity |
| 09/15/2011 | WO2011112915A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses |
| 09/15/2011 | WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011110051A1 Inductive production of pluripotent stem cells using synthetic transcription factors |
| 09/15/2011 | WO2011110049A1 Anti-hiv fusion polypeptide and use thereof |
| 09/15/2011 | WO2011050052A3 Protein agent for diabetes treatment and beta cell imaging |
| 09/15/2011 | WO2010104749A8 Antigen presenting cell targeted cancer vaccines |
| 09/15/2011 | US20110223686 Protein production method, fusion protein, and antiserum |
| 09/15/2011 | US20110223200 Novel compositions and methods |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223184 Dkk2 protein and use thereof |